000 01471 a2200337 4500
005 20250515173313.0
264 0 _c20100323
008 201003s 0 0 eng d
022 _a1748-720X
024 7 _a10.1111/j.1748-720X.2009.00366.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBird, Robert C
245 0 0 _aDeveloping nations and the compulsory license: maximizing access to essential medicines while minimizing investment side effects.
_h[electronic resource]
260 _bThe Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics
_c2009
300 _a209-21 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aChild
650 0 4 _aDeveloping Countries
_xeconomics
650 0 4 _aDrug Costs
_xlegislation & jurisprudence
650 0 4 _aDrug Industry
_xeconomics
650 0 4 _aDrug and Narcotic Control
_xeconomics
650 0 4 _aDrugs, Essential
_xeconomics
650 0 4 _aHealth Services Accessibility
_xeconomics
650 0 4 _aHumans
650 0 4 _aInternational Cooperation
_xlegislation & jurisprudence
650 0 4 _aMandatory Programs
_xlegislation & jurisprudence
650 0 4 _aPatents as Topic
_xethics
773 0 _tThe Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics
_gvol. 37
_gno. 2
_gp. 209-21
856 4 0 _uhttps://doi.org/10.1111/j.1748-720X.2009.00366.x
_zAvailable from publisher's website
999 _c18917480
_d18917480